Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 164 for “"VIF"”.
-
Entwicklung von vif-Elongin-C-Interaktionsinhibitoren als neuartige HIV-Therapeutika
… humanen retroviralen Schutzes. Durch Hemmung der vif–Elongin-C-Interaktion mit Elongin-C-Inhibitoren bleibt der Organismus in der Lage, sich mithilfe von APOBEC3G auf natürlichem Wege vor dem HI-Virus zu schützen, unabhängig von viralen Mutationen. Aufgrund der Tatsachen, dass die Kristallstruktur …
-
The Dynamic Interplay Between Lentiviral Vif and Human APOBEC3 Proteins
… HIV-1 counteracts restriction with its Vif protein, which nucleates a ubiquitin ligase complex that directly binds A3 enzymes and targets them for proteasomal degradation. My thesis research aims at understanding the dynamic interplay between lentiviral Vif and human A3 enzymes, from the …
-
Structural studies of HIV-1 Vif and its SOCS-box domain
… cells. The viral infectivity factor (Vif) can induce a poly-ubiquitination degradation of APOBEC3G to counteract the immune response by forming an E3 ubiquitin complex composed of cellular proteins Elongin B (EloB), Elongin C (EloC), Cullin 5 and Ring-Box protein. In this project, we …
-
Dynamics of the mammalian APOBEC3 locus and the relationship between mammalian APOBEC3 and Lentiviral Vif proteins.
… (A3) proteins and HIV viral infectivity factor (Vif) protein. A3 proteins are cytosine deaminases that primarily inhibit retroviruses and retrotransposons by mutating cytosines to uracils in retroviral DNA during reverse transcription. When HIV Vif is present, it can bind to certain A3 proteins …
-
Inhibition of HIV-1 Vif by Pokeweed Antiviral Protein and its Impact on Cellular Immune Defense
… accessory protein viral infectivity factor (Vif) targets APOBEC3G for degradation. The objective of this work was to evaluate whether the inhibitory effect of Vif on A3G can be diminished by pokeweed antiviral protein (PAP). PAP is an N-glycosidase synthesized by the pokeweed plant, …
-
Etablierung von zellulären Testsystemen für die Identifizierung von neuartigen Inhibitoren des HIV-1 Vif-induzierten APOBEC3G-Abbaus
… Wirkung von A3G kodiert HIV-1 das Protein Vif (virion infectivity factor), welches durch eine direkte Wechselwirkung den Ubiquitin-abhängigen proteasomalen Abbau von A3G bewirkt. Vor diesem Hintergrund wird der Inhibition des Vif induzierten A3G- Abbaus großes Potential als neuartiges …
-
Proviral HIV-1 hypermutation: the correlation of APOBEC3G/F and HIV-1 Vif in HIV-1 disease progression
… proteins through protein interactions with HIV-1 Vif. The aim of this thesis is to characterize and investigate the role of APOBEC3G/F-mediated hypermutation in the HIV-1 genome. We identified a subset of women from the Pumwani Commercial Sex Worker (CSW) cohort with significantly higher rates of …
-
HIV-1 Vif requires core binding factor Beta to degrade the APOBEC3 restriction factors and facilitate viral replication
… proteins and the HIV counterdefense protein, Vif. Vif binds to and neutralizes the DNA-mutating APOBEC3 proteins by recruitment of an E3 ubiquitin ligase complex that targets them for degradation. Design of small molecule therapeutics to disrupt this interaction and free the antiviral APOBEC3 …
-
Viral Infectivity Factors of Human Immunodeficiency Viruses: Functional Convergence Through Structural Divergence
… protein named viral infectivity factor (Vif). The HIV Vif encodes for several functionalities that are collectively aimed at disarming an immunological pathway in humans. The apolipoprotein B mRNA-editing catalytic polypeptide-like 3 (APOBEC3/A3) proteins embody this immunological pathway …
-
Funktionsanalyse von Derivaten des HIV-Antagonisten RN18, sowie potentieller weiterer Vif/Apobec-Hemmstoffe mittels eines Zell-basierten Fluoreszenz Screeningverfahrens
… der Interaktion der Gegenspieler Apobec3G und Vif, ein neuartiges Medikament gegen HIV zu entwickeln, ist in der Literatur bereits vielfach beschrieben (Argyris und Pomerantz 2004, Cullen 2006, Sheehy et al. 2003). Als Teil des angeborenen Immunsystems bietet die Aufrechterhaltung der …
-
Funktionsanalyse von Derivaten des HIV-Antagonisten RN18, sowie potentieller weiterer Vif/Apobec-Hemmstoffe mittels eines Zell-basierten Fluoreszenz Screeningverfahrens
… der Interaktion der Gegenspieler Apobec3G und Vif, ein neuartiges Medikament gegen HIV zu entwickeln, ist in der Literatur bereits vielfach beschrieben (Argyris und Pomerantz 2004, Cullen 2006, Sheehy et al. 2003). Als Teil des angeborenen Immunsystems bietet die Aufrechterhaltung der …
-
Muhammad Khalil Thesis
… hindered by the HIV-1 Viral Infectivity Factor (Vif). Vif enables the ubiquitination of APOBEC3 enzymes by a Cullin RING E3 Ligase complex, resulting in their subsequent degradation through the 26S proteasome. Vif exists in infected cells as a heterotetramer where Vif obligately binds the …
-
Lethal Hypermutation Induced by the Innate Cellular Restriction Factor APOBEC Destroys HIV-1 in Infected Humanized Mice
… however, they are neutralized by the HIV-1 Vif protein. In vitro, the absence of Vif allows the enzymatic activity of APOBEC3G and 3F to induce hypermutation of the HIV-1 genome. These observations make the Vif/APOBEC axis a tantalizing therapeutic target. The ability of APOBEC to restrict …
-
Human immunodeficiency virus evasion of APOBEC3 restriction factors
… human immunodeficiency virus accessory protein Vif protects the viral genome from the mutational activity of APOBEC3 subfamily DNA cytosine deaminases by facilitating their proteasomal degradation, thereby preserving viral infectivity. A comprehensive understanding of the components of the …
-
Regional Differences in Adipose Tissue of the Sinclair Minipig
… the basal adipose tissue biology of visceral (VIF) and subcutaneous (SQF) fat depots in 8 month old Sinclair minipigs, an animal that has been shown to be physiologically similar to humans.</p> <p>Metabolic analysis showed a decrease in LDL, white blood cells (WBC), and lymphocyte percentages …
-
Molecular mechanisms of human innate immune restriction factors APOBEC3G and APOBEC3H for inhibiting the retrovirus HIV-1 and retrotransposon LINE1
… occurs most potently in the absence of HIV-1 Vif, which counteracts APOBEC3s by inducing polyubiquitination and subsequent degradation of APOBEC3 enzymes. Virion-encapsidated APOBEC3s can deaminate cytosines to uracils in viral (-)DNA. Upon replication of (-)DNA to (+)DNA, the HIV-1 reverse …
Page 1 of 9